Galena Biopharma, Inc.
(NASDAQ : GALE)

( )
GALE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading GALE News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.96%164.701.2%$479.34m
GILDGilead Sciences, Inc.
1.31%67.121.0%$477.88m
BIIBBiogen Inc.
3.62%286.891.2%$430.46m
CELGCelgene Corporation
1.92%125.521.1%$374.36m
REGNRegeneron Pharmaceuticals, Inc.
0.13%372.432.7%$322.82m
VRTXVertex Pharmaceuticals Incorporated
-0.33%117.271.8%$289.46m
INCYIncyte Corporation
0.39%124.392.1%$254.11m
ALXNAlexion Pharmaceuticals, Inc.
0.85%120.551.6%$218.34m
ILMNIllumina, Inc.
0.72%181.503.3%$166.56m
TSROTESARO, Inc.
0.94%138.4415.3%$142.12m
NBIXNeurocrine Biosciences, Inc.
3.55%53.624.5%$102.87m
BMRNBioMarin Pharmaceutical Inc.
0.72%94.194.3%$98.65m
KITEKite Pharma, Inc.
-2.04%80.5715.6%$97.22m
CLVSClovis Oncology, Inc.
1.65%57.8618.2%$93.56m
AAgilent Technologies, Inc.
0.70%54.821.6%$87.06m

Company Profile

Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.